SA
PCVX icon

Sanctuary Advisors’s Vaxcyte PCVX Stock Holding History

Sanctuary Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Sell
5,596
-668
-11% -$36.3K ﹤0.01% 2269
2026
Q1 		$364K Buy
6,264
+1,595
+34% +$86.6K ﹤0.01% 1975
2025
Q4 		$215K Buy
+4,669
New +$209K ﹤0.01% 2240
2025
Q3 		– Sell
-7,724
Closed -$251K – 2522
2025
Q2 		$251K Buy
7,724
+1,318
+21% +$43.2K ﹤0.01% 2022
2025
Q1 		$242K Buy
6,406
+721
+13% +$57.6K ﹤0.01% 1926
2024
Q4 		$523K Buy
5,685
+1,248
+28% +$124K ﹤0.01% 1657
2024
Q3 		$393K Buy
+4,437
New +$400K ﹤0.01% 1846

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Sanctuary Advisors's PCVX Position: Q2 2026 in Review

Sanctuary Advisors reduced its Vaxcyte (PCVX) stake by 11% in Q2 2026, selling an estimated $36.3K and leaving 5,596 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Sanctuary Advisors first reported a position in PCVX in Q3 2024 and has held it in 7 quarters since. The position peaked at $523K in Q4 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Sanctuary Advisors held 5,596 shares of Vaxcyte worth $325K as of Q2 2026.
  • Sanctuary Advisors sold 668 Vaxcyte shares in Q2 2026, an estimated $36.3K.
  • Vaxcyte made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2269 holding.
  • Sanctuary Advisors first reported a position in Vaxcyte in Q3 2024 and has held it in 7 quarters since.
  • Sanctuary Advisors's Vaxcyte position peaked at $523K in Q4 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.